Viral Infections & Inflammation Workshop 2023

Update on the REPRIEVE Trial to Prevent Cardiovascular Events in People with HIV - Steven Grinspoon, MD

Video

HIV

RSV

COVID-19

Underlying Mechanisms of Long COVID - Michael Peluso, MD

Viruses, Immune Dysfunction, and ME/CFS - Maureen Hanson, PhD

High Levels of Il-1, Tnf- and Mip-1 One Month after the Onset of the Acute SARS-CoV-2 Infection, Predictors of Post COVID-19 in Hospitalized Patients - Jacobo Alonso-Domínguez

Determinants of the Onset and Prognosis of the Post-COVID-19 Condition: A 2-Year Prospective Cohort Study - Roger Paredes, PhD

Immunopathology of viral encephalitis - Avindra Nath, MD

Epstein–Barr Virus and Multiple Sclerosis: Which Mechanisms are at Play? - Tobias Lanz, MD

What We Know Now about HIV and Long COVID - Annie Antar, MD, PhD

Post-acute Sequelae following Ebola infection - David Wohl, MD

HIV Exposed Uninfected (Heu) Infants Have Pro-inflammatory Bioprofiles That Correlate with Their Mothers’ Bioprofiles Independent of Viral Levels and Persist for at Least Six Months - Li Yin

Possible Role of Intestinal Damage and Endotoxemia in the Development of Endotholial Dysfunction, Thrombosis and Secondary Lung Damage in Patients with COVID-19 - Liudmyla Shostakovych-Koretskaya

HIV, Inflammation, and Macrophages - Maureen M. Goodenow, PhD

The Plasma Microbiome Contributes to Immune Reconstitution in HIV Infected Individuals on Suppressive ART - Wei Jiang

Developing CAR T Cells for Use in Chronic HIV Infection - Martin Tolstrup, MSc, PhD

Inflammasome Activation in Severe Cases of COVID-19 - Dario Zamboni, PhD

Viral Infections & Inflammation Workshop 2023

Update on the REPRIEVE Trial to Prevent Cardiovascular Events in People with HIV - Steven Grinspoon, MD

Underlying Mechanisms of Long COVID - Michael Peluso, MD

Viruses, Immune Dysfunction, and ME/CFS - Maureen Hanson, PhD

High Levels of Il-1, Tnf- and Mip-1 One Month after the Onset of the Acute SARS-CoV-2 Infection, Predictors of Post COVID-19 in Hospitalized Patients - Jacobo Alonso-Domínguez

Determinants of the Onset and Prognosis of the Post-COVID-19 Condition: A 2-Year Prospective Cohort Study - Roger Paredes, PhD

Immunopathology of viral encephalitis - Avindra Nath, MD

Epstein–Barr Virus and Multiple Sclerosis: Which Mechanisms are at Play? - Tobias Lanz, MD

What We Know Now about HIV and Long COVID - Annie Antar, MD, PhD

Post-acute Sequelae following Ebola infection - David Wohl, MD

HIV Exposed Uninfected (Heu) Infants Have Pro-inflammatory Bioprofiles That Correlate with Their Mothers’ Bioprofiles Independent of Viral Levels and Persist for at Least Six Months - Li Yin

Possible Role of Intestinal Damage and Endotoxemia in the Development of Endotholial Dysfunction, Thrombosis and Secondary Lung Damage in Patients with COVID-19 - Liudmyla Shostakovych-Koretskaya

HIV, Inflammation, and Macrophages - Maureen M. Goodenow, PhD

The Plasma Microbiome Contributes to Immune Reconstitution in HIV Infected Individuals on Suppressive ART - Wei Jiang

Developing CAR T Cells for Use in Chronic HIV Infection - Martin Tolstrup, MSc, PhD

Inflammasome Activation in Severe Cases of COVID-19 - Dario Zamboni, PhD

Endogeneous Retroviruses and Inflammation - Yasmine Belkaid, PhD